Anzeige
Mehr »
Montag, 21.07.2025 - Börsentäglich über 12.000 News
Alarm am Metallmarkt: Kupfer unter Strom: USA rüsten sich - was das für Anleger bedeutet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBJC | ISIN: US03837C1062 | Ticker-Symbol: BOV
Frankfurt
21.07.25 | 08:06
1,880 Euro
-1,05 % -0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
APYX MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
APYX MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,8801,91020:08
1,8801,91019:59

Aktuelle News zur APYX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.05.Apyx Medical Announces FDA Clearance For AYON Body Contouring System4
13.05.Apyx Medical gets FDA nod for AYON Body Contouring System2
13.05.Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System210The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion...
► Artikel lesen
08.05.Apyx Medical Corp - 10-Q, Quarterly Report-
08.05.Apyx Medical Corp - 8-K, Current Report-
29.04.Apyx Medical Corp - 8-K, Current Report1
29.04.Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures2
24.04.Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 20252
APYX MEDICAL Aktie jetzt für 0€ handeln
31.03.Citizens JMP maintains Apyx Medical stock at Market Perform1
14.03.Apyx Medical Corporation (NASDAQ:APYX) Q4 2024 Earnings Call Transcript1
13.03.Apyx Medical Corp - 10-K, Annual Report1
13.03.Apyx Medical Corporation Q4 Loss Decreases1
13.03.Apyx Medical GAAP EPS of -$0.12 beats by $0.04, revenue of $14.22M beats by $0.83M1
13.03.Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results210The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last yearSubmitted a 510(k) premarket notification...
► Artikel lesen
13.03.Apyx Medical Corp - 8-K, Current Report1
27.02.Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 20251
06.02.Apyx Medical Corp - 8-K, Current Report-
06.01.Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System245CLEARWATER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology...
► Artikel lesen
08.11.24Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook174Strengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants for the Company's credit agreement with PerceptiveAnnounces...
► Artikel lesen
08.08.24Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook201CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1